NAHSV Healthlinko Private Limited today announced the completion of its first year of operations, marking a milestone defined by profitable growth, expanding patient reach and growing international momentum led by its flagship healthcare platform, MediFyr.
Founded in April 2025 with a vision to improve healthcare access through technology-enabled solutions, the company has in one year established a growing presence across digital health and wellness, while building a scalable and sustainable operating model.
At the center of this growth has been MediFyr, which has emerged as the company’s flagship brand and principal growth engine. The platform currently supports more than 2,000 patients every month, helping address medical needs through improved healthcare discovery, patient support and access facilitation.
This momentum contributed to ₹65 lakh in revenue in the last quarter of the previous financial year, reflecting strong early traction and growing market confidence in the company’s model.
NAHSV Healthlinko said these milestones have been achieved without external investment, with the company operating as a bootstrapped and profitable venture during its foundational year. Management said this approach has enabled the business to scale with financial discipline while building long-term value on strong operating fundamentals.
“The first year has been about building credibility, earning trust and proving the strength of the model,” the company said in a statement. “What has been built through MediFyr provides a strong foundation for the next phase of growth.”
Alongside MediFyr, the company has continued expanding its broader portfolio — including Zerunio, WhatPregnant, HealthSetu and Unikorn — supporting a long-term strategy of building a diversified digital health ecosystem.
As the company enters its second year, international expansion has emerged as a major strategic focus. Through MediFyr, the company has already established partnerships and signed hospitals across Turkey, Egypt, Israel, Thailand, UAE and China, creating an early global network designed to support cross-border healthcare access and international patient facilitation.
The company said these partnerships represent the beginning of a broader international growth strategy, with further expansion expected as MediFyr strengthens its presence across global markets.
Looking ahead, NAHSV Healthlinko said its priorities include scaling patient reach, strengthening technology infrastructure, deepening strategic partnerships and expanding MediFyr’s international footprint.
With revenue growth, patient impact and international partnerships already established, NAHSV Healthlinko believes it is entering its second year positioned for a larger scale of opportunity.
This press release is provided by a third party. The website does not verify its accuracy and is not responsible for its content or any resulting claims.
